Axitinib in combination with pembrolizumab in patients (pts) with advanced renal cell carcinoma (aRCC): Preliminary safety and efficacy results

Axitinib in combination with pembrolizumab in patients (pts) with advanced renal cell carcinoma (aRCC): Preliminary safety and efficacy results

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 27; p. vi266
Main Authors: Atkins, M.B., Plimack, E.R., Puzanov, I., Fishman, M.N., McDermott, D., Cho, D.C., Vaishampayan, U., George, S., Olencki, T., Tarazi, J., Rosbrook, B., Fernandez, K., Keefe, S., Choueiri, T.
Format: Journal Article
Language:English
Published: Elsevier Ltd 01-10-2016
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdw373.01